share_log

Intelligent Bio Solutions Submits 510(k) Premarket Notification To US FDA For Fingerprint Sweat-Based Drug Screening Technology

Intelligent Bio Solutions Submits 510(k) Premarket Notification To US FDA For Fingerprint Sweat-Based Drug Screening Technology

智能生物解決方案向美國食品藥品監督管理局提交了基於指紋汗液的藥物篩查技術的510(k)上市前通知。
Benzinga ·  2024/12/18 21:33

Intelligent Bio Solutions Submits 510(k) Premarket Notification To US FDA For Fingerprint Sweat-Based Drug Screening Technology

智能生物解決方案向美國食品藥品監督管理局提交了基於指紋汗液的藥物篩查技術的510(k)上市前通知。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論